Advanced company searchLink opens in new window

ARCHIMEDES PHARMA UK LIMITED

Company number 02530982

Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
26 Sep 2024 CS01 Confirmation statement made on 26 September 2024 with no updates
07 Feb 2024 AA Accounts for a dormant company made up to 31 December 2022
27 Sep 2023 AP01 Appointment of Antrinkos Andrew Aristidou as a director on 26 September 2023
27 Sep 2023 TM01 Termination of appointment of Alan Fernie King as a director on 26 September 2023
26 Sep 2023 CS01 Confirmation statement made on 26 September 2023 with updates
16 Aug 2023 CS01 Confirmation statement made on 14 August 2023 with no updates
01 Feb 2023 CH01 Director's details changed for Alan Fernie King on 1 February 2023
01 Feb 2023 CH01 Director's details changed for Dr Roswitha Reisinger on 1 February 2023
01 Feb 2023 CH01 Director's details changed for Alan Fernie King on 1 February 2023
05 Oct 2022 AA Full accounts made up to 31 December 2021
18 Aug 2022 CS01 Confirmation statement made on 14 August 2022 with updates
22 Jul 2022 PSC02 Notification of Kyowa Kirin International Plc as a person with significant control on 10 September 2021
22 Jul 2022 PSC07 Cessation of Archimedes Pharma Ltd as a person with significant control on 10 September 2021
05 Jan 2022 CH01 Director's details changed for Dr Roswitha Reisinger on 5 January 2022
13 Sep 2021 CH01 Director's details changed for Alan Fernie King on 10 September 2021
11 Sep 2021 AA Full accounts made up to 31 December 2020
10 Sep 2021 CS01 Confirmation statement made on 14 August 2021 with no updates
10 Sep 2021 SH20 Statement by Directors
10 Sep 2021 SH19 Statement of capital on 10 September 2021
  • GBP 1.00
10 Sep 2021 CAP-SS Solvency Statement dated 02/08/21
10 Sep 2021 RESOLUTIONS Resolutions
  • RES13 ‐ Cancellation of share premium account 02/08/2021
  • RES06 ‐ Resolution of reduction in issued share capital
10 Dec 2020 CH01 Director's details changed for Dr Roswitha Reisinger on 10 December 2020
16 Sep 2020 AA Full accounts made up to 31 December 2019
01 Sep 2020 CS01 Confirmation statement made on 14 August 2020 with updates
29 Apr 2020 TM01 Termination of appointment of Allan Mark Watson as a director on 22 April 2020